Reversing Time: Ezh1 Deficiency Hastens Definitive Hematopoiesis

Publication date: 1 March 2018
Source:Cell Stem Cell, Volume 22, Issue 3
Author(s): April C. Apostol, Anna E. Beaudin
The inability to derive multipotent hematopoietic stem cells in vitro stems in part from a limited understanding of how multipotency is acquired during development. Recently in Nature,Vo et al. (2018) reveal the epigenetic enzyme Ezh1 as a master regulator of multipotency during hematopoietic stem cell development.

Teaser

The inability to derive multipotent hematopoietic stem cells in vitro stems in part from a limited understanding of how multipotency is acquired during development. Recently in Nature, Vo et al. (2018) reveal the epigenetic enzyme Ezh1 as a master regulator of multipotency during hematopoietic stem cell development.


http://ift.tt/2oJFNB1